GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » EV-to-FCF

Stryker (Stryker) EV-to-FCF : 44.09 (As of Apr. 26, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Stryker EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Stryker's Enterprise Value is $138,274 Mil. Stryker's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $3,136 Mil. Therefore, Stryker's EV-to-FCF for today is 44.09.

The historical rank and industry rank for Stryker's EV-to-FCF or its related term are showing as below:

SYK' s EV-to-FCF Range Over the Past 10 Years
Min: 13.97   Med: 41.45   Max: 83.96
Current: 44.07

During the past 13 years, the highest EV-to-FCF of Stryker was 83.96. The lowest was 13.97. And the median was 41.45.

SYK's EV-to-FCF is ranked worse than
68.38% of 370 companies
in the Medical Devices & Instruments industry
Industry Median: 25.87 vs SYK: 44.07

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-26), Stryker's stock price is $336.68. Stryker's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $8.250. Therefore, Stryker's PE Ratio for today is 40.81.


Stryker EV-to-FCF Historical Data

The historical data trend for Stryker's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker EV-to-FCF Chart

Stryker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.31 36.96 40.33 50.94 39.47

Stryker Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.94 52.79 52.68 44.61 39.47

Competitive Comparison of Stryker's EV-to-FCF

For the Medical Devices subindustry, Stryker's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stryker's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Stryker's EV-to-FCF falls into.



Stryker EV-to-FCF Calculation

Stryker's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=138274.473/3136
=44.09

Stryker's current Enterprise Value is $138,274 Mil.
Stryker's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3,136 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stryker  (NYSE:SYK) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Stryker's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=336.68/8.250
=40.81

Stryker's share price for today is $336.68.
Stryker's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.250.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Stryker EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Stryker's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Stryker (Stryker) Business Description

Address
2825 Airview Boulevard, Kalamazoo, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Executives
Srikant Datar director ICF INTERNATIONAL, INC., 9300 LEE HIGHWAY, FAIRFAX VA 22031
Berry William E Jr officer: Vice President, Controller 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Kevin Lobo officer: Group Pres., Neurotech & Spine STRYKER, 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Viju Menon officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Allan C. Golston director 2825 AIRVIEW BLVD., KALAMAZOO MI 49002
Ronda E Stryker director 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher officer: VP, Chief Legal Officer 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
James Andrew Pierce officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Glenn S Boehnlein officer: Vice President, CFO 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink officer: VP, Global Human Resources 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio director BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Timothy J Scannell officer: Group President 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Roch Doliveux director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Katherine Ann Owen officer: VP 2825 AIRVIEW BLVD., KALAMAZOO MI 49002

Stryker (Stryker) Headlines

From GuruFocus

Stryker Corp Corporate Analyst Meeting Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2021 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Stryker Corp To Host Investor Day Transcript

By GuruFocus Research 01-23-2024

Stryker Corp Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Q2 2020 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024